Literature DB >> 30811776

Growth and growth hormone in Turner syndrome: Looking back, looking ahead.

Evan Los1, Ron G Rosenfeld2.   

Abstract

Short stature is the most ubiquitous feature of Turner syndrome (TS). Today, many girls with TS are treated with recombinant human growth hormone (GH) to accelerate growth in childhood and to improve adult height. Here, we will review the history of our understanding of growth in TS, reflect on the path of clinical trials ultimately leading to regulatory approval for clinical use of GH, discuss factors associated with growth outcomes and survey the current unanswered questions about growth and GH in TS.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Turner syndrome; growth; growth hormone

Mesh:

Substances:

Year:  2019        PMID: 30811776     DOI: 10.1002/ajmg.c.31680

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  2 in total

1.  Main Physical Features, Echocardiographic and Renal Ultrasonographic Findings of Turner Syndrome in 107 Pediatric Patients.

Authors:  Akçahan Akalın; İlker Ertuğrul; Pelin Özlem Şimşek-Kiper; Gülen Eda Utine; Koray Boduroğlu
Journal:  Mol Syndromol       Date:  2021-08-12

Review 2.  Hydrogels For Peptide Hormones Delivery: Therapeutic And Tissue Engineering Applications.

Authors:  Mohsen Doostmohammadi; Atefeh Ameri; Reza Mohammadinejad; Negar Dehghannoudeh; Ibrahim M Banat; Mandana Ohadi; Gholamreza Dehghannoudeh
Journal:  Drug Des Devel Ther       Date:  2019-09-26       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.